Anders Hedegaard

Anders Hedegaard is an accomplished executive with extensive experience in leadership roles across various companies in the pharmaceutical and healthcare sectors. Currently serving as Chairman of the Board for Ellab since October 2023 and ALK, Anders also holds a position as a Non-Executive Board member and advisor at Rodenstock. Previous roles include CEO and President at GN Hearing A/S and Bavarian Nordic A/S, along with board membership at Orphazyme A/S and Origio A/S. With a strong foundation in international sales and marketing from positions at ALK-Abello A/S, FOSS A/S, and Novo Nordisk A/S, Anders holds a Master of Science in Chemical Engineering from The Technical University of Denmark, complemented by advanced management and international directors program certifications from INSEAD.